Twitxy Saved

Nazrul Islam

@_Nazrul_Islam

Assoc Prof @UoS_Medicine; Research Editor @bmj_latest; Sr Advisor @ONS; formerly @UniofOxford @Cambridge_Uni; @Harvard alum; personal A/C; (re)tweet≠endorsement
Oxford, England southampton.ac.uk/people/626r7t/… Joined August 2014
351 Following 324 Followers 1.2K Posts

Latest posts 5

Nazrul Islam @_Nazrul_Islam
Our #RCT just published in @JAMA_current

It's been a wonderful experience to mentor & co-supervise this very important trial that fills a critical gap in the literature and clinical guidelines.
jamanetwork.com/journals/jama/…
@UoSMedia @unisouthampton @UoS_PrimaryCare @ZJU_China
jamanetwork.com Intraoperative Dobutamine Plus Norepinephrine to Prevent Postoperative AKI in Septic Shock This randomized open-label clinical trial examines whether intraoperative dobutamine combined with norepinephrine reduces acute kidney injury (AKI) within 7 postoperative days in surgical patients...
JAMA Verified account @JAMA_current Oct 14
🧵 Presented today at #LIVES2026:

Among patients with #SepticShock undergoing surgical source control, intraoperative dobutamine plus norepinephrine reduced new-onset or worsening #AcuteKidneyInjury within 7 days after surgery compared with norepinephrine alone. These findings support consideration of this intraoperative hemodynamic strategy for reducing postoperative kidney injury in this surgical population.

ja.ma/4dF23oY
View quoted post on X
Nazrul Islam @_Nazrul_Islam
#TARGET guideline on #trial #emulation is now published in @JAMA_current and @bmj_latest
jamanetwork.com/journals/jama/…
bmj.com/content/390/bm…
Amazing experience working with some of the best minds in #CausalInference
jamanetwork.com TARGET 2025 Statement This Special Communication introduces the Transparent Reporting of Observational Studies Emulating a Target Trial (TARGET) 2025 guideline, a consensus-based guidance for reporting observational...
🎯 TARGET Guideline published 🎉

TARGET is a reporting guideline for observational studies of interventions that use the target trial framework.

Over 3 years it was rigorously developed and was co-published today in @JAMA_current & @bmj_latest

doi.org/10.1001/jama.2…
View quoted post on X